Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More

Labor Day is just around the corner and many people are looking forward to a last chance to celebrate the waning days of summer. But ahead of the holiday weekend, biopharmaceutical companies were hard at work closing deals. Food conglomerate Nestlé is delving deeper into pharmaceuticals with its $2.6 billion deal to acquire Aimmune Therapeutics, […]

Click to view original post